会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • Graham Power, a new method of generating power
    • 格雷厄姆电力,一种新的发电方式
    • US20080092542A1
    • 2008-04-24
    • US11973619
    • 2007-10-09
    • David Graham
    • David Graham
    • F01K25/08
    • F01K25/10
    • Titled “Graham Power, A New Method of Generating Power” inventor David Graham. Graham power is a power plant. In its simplest form, it is an air conditioning/refrigerant system which also produces power. This is accomplished by adding a turbine to an air-conditioning system. The evaporation process extract heat from the air and the turbine converts that heat into power. In fact it is a power generating system. Graham Power recycles the very fuel that it uses. Graham Power does not consume fuel nor does it release CO2 gas to the environment. It simply draws heat from the surrounding air and transforms it into useful power. In the process of extracting heat from the environment it cools the air. This cooling effect is beneficial to the atmosphere which is currently overheating.
    • 发明人David Graham的“Graham Power,一种新的发电方式”。 格雷厄姆电力是一个发电厂。 在最简单的形式下,它也是一个也产生电力的空调/制冷系统。 这通过将涡轮机添加到空调系统来实现。 蒸发过程从空气和涡轮机中提取热量将热量转化为动力。 实际上它是发电系统。 格雷厄姆电力公司回收使用的燃料。 Graham Power不消耗燃料,也不释放二氧化碳气体到环境中。 它只是从周围的空气中吸取热量,并将其转化为有用的能量。 在从环境中提取热量的过程中,它会冷却空气。 这种冷却效果有利于目前过热的气氛。
    • 9. 发明授权
    • Anti-viral azide containing compounds
    • 含抗病毒叠氮化合物的化合物
    • US09144575B2
    • 2015-09-29
    • US13192959
    • 2011-07-28
    • Brian AgnewDavid GrahamUpinder SinghScott Grecian
    • Brian AgnewDavid GrahamUpinder SinghScott Grecian
    • A61K31/655A61K31/7024A61K45/06
    • A61K31/655A61K31/7024A61K31/7088A61K38/212A61K38/215A61K45/06A61K2300/00
    • Methods of using azide-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to inhibit infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. Also, provided are methods of tracking a virus in vivo, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The azide-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.
    • 提供了使用叠氮化物修饰的生物分子如脂肪酸,碳水化合物和脂质来治疗植物,昆虫或感染病毒的动物或抑制病毒如人类免疫缺陷病毒的感染性的方法。 还提供了用叠氮化物修饰的生物分子如脂肪酸,碳水化合物或类异戊二烯脂质来标记病毒(例如人类免疫缺陷病毒)的方法。 此外,提供了利用叠氮化物修饰的生物分子如脂肪酸,碳水化合物或类异戊二烯脂质体内追踪病毒的方法。 叠氮化物修饰的生物分子可以与药学上可接受的赋形剂组合以产生药物组合物,任选地含有另一种抗病毒剂和/或递送剂,例如脂质体。